Pharyngeal Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: PD8FB1BAC049EN
Market Monitor Global

Abstracts

Some of the significant risk factors for pharyngeal cancer include the extended use of tobacco, excessive alcohol consumption, increasing viral infections, and occupational hazards. Tobacco smoke contains carcinogens that can damage DNA and develop unusual cells leading to cancer.

This report contains market size and forecasts of Pharyngeal Cancer Therapeutics in Global, including the following market information:

Global Pharyngeal Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pharyngeal Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharyngeal Cancer Therapeutics include AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., Roche, Merck & Co., Inc., Mylan NV, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharyngeal Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharyngeal Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pharyngeal Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Targeted Therapy
• Chemotherapy

Global Pharyngeal Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pharyngeal Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Pharyngeal Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pharyngeal Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharyngeal Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pharyngeal Cancer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca Plc
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• Roche
• Merck & Co., Inc.
• Mylan NV
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pharyngeal Cancer Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pharyngeal Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHARYNGEAL CANCER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Pharyngeal Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Pharyngeal Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pharyngeal Cancer Therapeutics Players in Global Market
3.2 Top Global Pharyngeal Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Pharyngeal Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Pharyngeal Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharyngeal Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharyngeal Cancer Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Pharyngeal Cancer Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pharyngeal Cancer Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pharyngeal Cancer Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Targeted Therapy
  4.1.3 Chemotherapy
4.2 By Type - Global Pharyngeal Cancer Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Pharyngeal Cancer Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Pharyngeal Cancer Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pharyngeal Cancer Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Pharyngeal Cancer Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Pharyngeal Cancer Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Pharyngeal Cancer Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pharyngeal Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Pharyngeal Cancer Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Pharyngeal Cancer Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Pharyngeal Cancer Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pharyngeal Cancer Therapeutics Revenue, 2017-2028
  6.3.2 US Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.3.3 Canada Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Pharyngeal Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pharyngeal Cancer Therapeutics Revenue, 2017-2028
  6.4.2 Germany Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.4.3 France Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.4.5 Italy Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.4.6 Russia Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Pharyngeal Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pharyngeal Cancer Therapeutics Revenue, 2017-2028
  6.5.2 China Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.5.3 Japan Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.5.6 India Pharyngeal Cancer Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pharyngeal Cancer Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Pharyngeal Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pharyngeal Cancer Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.7.3 Israel Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Pharyngeal Cancer Therapeutics Market Size, 2017-2028
  6.7.5 UAE Pharyngeal Cancer Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca Plc
  7.1.1 AstraZeneca Plc Corporate Summary
  7.1.2 AstraZeneca Plc Business Overview
  7.1.3 AstraZeneca Plc Pharyngeal Cancer Therapeutics Major Product Offerings
  7.1.4 AstraZeneca Plc Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Plc Key News
7.2 Bristol-Myers Squibb Co.
  7.2.1 Bristol-Myers Squibb Co. Corporate Summary
  7.2.2 Bristol-Myers Squibb Co. Business Overview
  7.2.3 Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Major Product Offerings
  7.2.4 Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Co. Key News
7.3 Eli Lilly and Co.
  7.3.1 Eli Lilly and Co. Corporate Summary
  7.3.2 Eli Lilly and Co. Business Overview
  7.3.3 Eli Lilly and Co. Pharyngeal Cancer Therapeutics Major Product Offerings
  7.3.4 Eli Lilly and Co. Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly and Co. Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Pharyngeal Cancer Therapeutics Major Product Offerings
  7.4.4 Roche Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Merck & Co., Inc.
  7.5.1 Merck & Co., Inc. Corporate Summary
  7.5.2 Merck & Co., Inc. Business Overview
  7.5.3 Merck & Co., Inc. Pharyngeal Cancer Therapeutics Major Product Offerings
  7.5.4 Merck & Co., Inc. Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Merck & Co., Inc. Key News
7.6 Mylan NV
  7.6.1 Mylan NV Corporate Summary
  7.6.2 Mylan NV Business Overview
  7.6.3 Mylan NV Pharyngeal Cancer Therapeutics Major Product Offerings
  7.6.4 Mylan NV Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Mylan NV Key News
7.7 Pfizer Inc.
  7.7.1 Pfizer Inc. Corporate Summary
  7.7.2 Pfizer Inc. Business Overview
  7.7.3 Pfizer Inc. Pharyngeal Cancer Therapeutics Major Product Offerings
  7.7.4 Pfizer Inc. Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Inc. Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Pharyngeal Cancer Therapeutics Major Product Offerings
  7.8.4 Sanofi Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Sun Pharmaceutical Industries Ltd.
  7.9.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
  7.9.2 Sun Pharmaceutical Industries Ltd. Business Overview
  7.9.3 Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Major Product Offerings
  7.9.4 Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Industries Ltd. Key News
7.10 Teva Pharmaceutical Industries Ltd.
  7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.10.3 Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Major Product Offerings
  7.10.4 Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Teva Pharmaceutical Industries Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pharyngeal Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Pharyngeal Cancer Therapeutics Market Drivers in Global Market
Table 3. Pharyngeal Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Pharyngeal Cancer Therapeutics in Global Market
Table 5. Top Pharyngeal Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharyngeal Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharyngeal Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharyngeal Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Pharyngeal Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharyngeal Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharyngeal Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharyngeal Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharyngeal Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharyngeal Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharyngeal Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharyngeal Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Plc Corporate Summary
Table 31. AstraZeneca Plc Pharyngeal Cancer Therapeutics Product Offerings
Table 32. AstraZeneca Plc Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Co. Corporate Summary
Table 34. Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly and Co. Corporate Summary
Table 37. Eli Lilly and Co. Pharyngeal Cancer Therapeutics Product Offerings
Table 38. Eli Lilly and Co. Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Pharyngeal Cancer Therapeutics Product Offerings
Table 41. Roche Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co., Inc. Corporate Summary
Table 43. Merck & Co., Inc. Pharyngeal Cancer Therapeutics Product Offerings
Table 44. Merck & Co., Inc. Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Mylan NV Corporate Summary
Table 46. Mylan NV Pharyngeal Cancer Therapeutics Product Offerings
Table 47. Mylan NV Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Inc. Corporate Summary
Table 49. Pfizer Inc. Pharyngeal Cancer Therapeutics Product Offerings
Table 50. Pfizer Inc. Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Pharyngeal Cancer Therapeutics Product Offerings
Table 53. Sanofi Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Industries Ltd. Corporate Summary
Table 55. Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Product Offerings
Table 56. Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 58. Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Product Offerings
Table 59. Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pharyngeal Cancer Therapeutics Segment by Type in 2021
Figure 2. Pharyngeal Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Pharyngeal Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharyngeal Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharyngeal Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharyngeal Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharyngeal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharyngeal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Plc Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly and Co. Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co., Inc. Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan NV Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Inc. Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)